NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

UCLA didn't develop DCVax-L by themselves, it was collaborative with NWBO as I understand it.

I believe that UCLA would handle this in a manner that's much like City of Hope does based on a presentation I attended where they discussed products that they truly did develop, like Herceptin. Essentially they find a company that will fund its development through the remainder of the clinical process and they receive a small royalty stream for doing so. The speaker didn't go into just how small the revenue stream was, but I'd have to guess that in a blockbuster drug like Herceptin, and other drugs based on it, like Kadcyla, they'd have brought in substantial money over the years.

I don't know that we'll ever get precise accounting for what UCLA will receive, but I believe they'll do quite well.

Gary